Warrants - Schedule of Activity of the Warrants (Details) - Warrants [Member] |
9 Months Ended | |
|---|---|---|
|
Dec. 31, 2024
$ / shares
shares
|
Sep. 30, 2025
$ / shares
shares
|
|
| Schedule of Activity of the Warrants [Line Items] | ||
| Number of Warrant, Grant | shares | ||
| Weighted Average Exercise Price, Grant | $ / shares | ||
| Number of Warrant, Exercised | shares | ||
| Weighted Average Exercise Price, Exercised | $ / shares | ||
| Number of Warrant, Cancelled | shares | ||
| Weighted Average Exercise Price, Cancelled | $ / shares | ||
| Number of Warrant, Outstanding | shares | 5,145,943 | 5,145,943 |
| Weighted Average Exercise Price, Outstanding | $ / shares | $ 0.25 | $ 0.25 |
| Weighted Average Remaining Life (Years), Outstanding | 2 years 10 months 6 days | 2 years 10 months 6 days |
| Number of Warrant, Exercisable | shares | 5,145,943 | |
| Weighted Average Exercise Price, Exercisable | $ / shares | $ 0.25 | $ 0.25 |
| Weighted Average Remaining Life (Years), Exercisable | 2 years 10 months 6 days |
| X | ||||||||||
- Definition The number of equity-based payment instruments, excluding stock (or unit) options, that were exercised during the reporting period. No definition available.
|
| X | ||||||||||
- Definition Weighted Average Remaining Life (Years), Exercisable. No definition available.
|
| X | ||||||||||
- Definition The number of shares into which fully or partially vested other than options outstanding as of the balance sheet date can be currently converted under the option plan. No definition available.
|
| X | ||||||||||
- Definition Weighted average grant-date fair value of other than options exercised. No definition available.
|
| X | ||||||||||
- Definition The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan). Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan). Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Weighted average remaining contractual term for equity-based awards excluding options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|